Coherus Biosciences | CHRS - 市值



金融业
股票价格
USD
资产
USD 258.34M
现金及等价物
USD 88.88M
销售成本
USD 4.05M
流动资产
USD 206.71M
流动负债
USD 140.39M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 61.01M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 171.9M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 3.17M
贸易债权人
USD 9.92M
应收帐款人
USD 18.42M


市值 更改 日
AbbVie USD 384.69B 19.14B 2026-03
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Fujifilm JPY 3.69T 340.04B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Merck USD 297.1B 35.84B 2026-03
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Xencor USD 893M 200M 2026-03
Zoetis USD 49.71B 5.74B 2026-03